Published in Diabetes Care on October 01, 1997
Correlates of insulin injection omission. Diabetes Care (2010) 3.03
The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med (2008) 2.85
Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PLoS One (2012) 1.44
Patient medication adherence: measures in daily practice. Oman Med J (2011) 1.29
Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc (2006) 1.27
Medication adherence in healthy elders: small cognitive changes make a big difference. J Aging Health (2009) 1.26
Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharm Pract (Granada) (2009) 1.20
A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures. Patient Prefer Adherence (2010) 1.19
The role of human factors in the design and development of an insulin pump. J Diabetes Sci Technol (2012) 1.15
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. Eur J Health Econ (2010) 1.08
Evidence-based mechanistic reasoning. J R Soc Med (2010) 1.06
Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary. Eur Child Adolesc Psychiatry (2006) 1.06
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular risk. BMC Public Health (2010) 0.93
Neuropsychological correlates of suboptimal adherence to metformin. J Behav Med (2003) 0.93
Adherence to glyburide and metformin and associated factors in type 2 diabetes in isfahan, iran. Iran J Pharm Res (2011) 0.92
Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat (2007) 0.90
Mobile health (mHealth) based medication adherence measurement - a pilot trial using electronic blisters in diabetes patients. Br J Clin Pharmacol (2013) 0.89
What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study. BMJ Open (2011) 0.89
Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination. Vasc Health Risk Manag (2008) 0.87
Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis. BMC Endocr Disord (2011) 0.86
Safety, tolerability, and efficacy of metformin extended-release oral antidiabetic therapy in patients with type 2 diabetes: an observational trial in Asia. J Diabetes (2012) 0.85
Validation of the Adherence Barriers Questionnaire - an instrument for identifying potential risk factors associated with medication-related non-adherence. BMC Health Serv Res (2015) 0.84
Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy. Eur J Clin Pharmacol (2010) 0.84
Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes. Diabetes Metab Syndr Obes (2011) 0.84
Effect of neighborhood factors on diabetes self-care behaviors in adults with type 2 diabetes. Diabetes Res Clin Pract (2014) 0.84
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects. J Clin Pharmacol (2016) 0.83
Performance of two questionnaires to measure treatment adherence in patients with Type-2 diabetes. BMC Public Health (2009) 0.83
Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag (2009) 0.83
Type D Personality Predicts Poor Medication Adherence in Chinese Patients with Type 2 Diabetes Mellitus: A Six-Month Follow-Up Study. PLoS One (2016) 0.81
The Role of Educational Level in Glycemic Control among Patients with Type II Diabetes Mellitus. Int J Health Sci (Qassim) (2014) 0.80
Cardiovascular medication: improving adherence. BMJ Clin Evid (2011) 0.80
Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes. Behav Med (2014) 0.79
Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet. Vasc Health Risk Manag (2008) 0.79
A hybrid Markov chain-von Mises density model for the drug-dosing interval and drug holiday distributions. AAPS J (2015) 0.78
An evaluation of patients' adherence with hypoglycemic medications among Papua New Guineans with type 2 diabetes: influencing factors. Patient Prefer Adherence (2014) 0.78
Gestational diabetes mellitus: insulinic management. J Obstet Gynaecol India (2014) 0.78
The Effect of Continuity of Care on Emergency Room Use for Diabetic Patients Varies by Disease Severity. J Epidemiol (2016) 0.77
Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study. Biomed Res Int (2013) 0.77
Lazy sunday afternoons: the negative impact of interruptions in patients' daily routine on adherence to oral antidiabetic medication. A multilevel analysis of electronic monitoring data. Eur J Clin Pharmacol (2013) 0.77
Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate. Patient Prefer Adherence (2009) 0.77
Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody. MAbs (2015) 0.76
Construction of a three-dimensional model of cardiovascular disease and deployment of a new method of fostering patient adherence to instruction. Patient Prefer Adherence (2013) 0.75
Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals. Integr Blood Press Control (2010) 0.75
Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese men. J Diabetes Investig (2016) 0.75
Nonadherence and factors affecting adherence of diabetic patients to anti-diabetic medication in Assela General Hospital, Oromia Region, Ethiopia. J Pharm Bioallied Sci (2016) 0.75
Do we prescribe what patients prefer? Pilot study to assess patient preferences for medication regimen characteristics. Patient Prefer Adherence (2012) 0.75
Association between Total Daily Doses with duration of hospitalization among readmitted patients in a multi-ethnic Asian population. Saudi Pharm J (2015) 0.75
Effect of Trelagliptin on Quality of Life in Patients with Type 2 Diabetes Mellitus: Study Protocol. Diabetes Ther (2017) 0.75
Cardiovascular medication: improving adherence using prompting mechanisms. BMJ Clin Evid (2015) 0.75
The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study. Pharm Pract (Granada) (2017) 0.75
Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. BMJ Open (2017) 0.75
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health (1992) 1.81
An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun (1999) 1.75
Conditional identification of phosphate-starvation-response mutants in Arabidopsis thaliana. Planta (2000) 1.68
Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol (2001) 1.66
Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens (1997) 1.62
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem (1995) 1.48
A gene for dihydrofolate reductase in a herpesvirus. Science (1988) 1.47
Non-puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol (1997) 1.46
Characterization of two classes of ribonucleoprotein complexes possibly involved in RNA editing from Leishmania tarentolae mitochondria. EMBO J (1994) 1.36
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem (1994) 1.33
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix. Int J Gynecol Pathol (1997) 1.24
Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records. Neth J Med (1999) 1.22
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Hum Pathol (1998) 1.18
Mapping of RNA transcribed from a region of the Herpesvirus saimiri genome required for oncogenicity. J Virol (1984) 1.14
T-DNA organization in homogeneous and heterogeneous octopine-type crown gall tissues of Nicotiana tabacum. Cell (1982) 1.14
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med (1998) 1.14
Scenario analysis of the future of medicines. BMJ (1994) 1.11
Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data. Pharm World Sci (1995) 1.10
Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg (1993) 1.10
Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol (2000) 1.10
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol (1996) 1.09
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer (1998) 1.08
Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up. Pharm World Sci (1998) 1.06
Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci (1999) 1.05
Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues. Anal Biochem (1997) 1.04
Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J Virol (1995) 1.03
Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep (2005) 1.03
Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements. Virus Genes (1996) 1.02
Existence of mature human CD4+ T cells with genuine class I restriction. Eur J Immunol (1992) 1.02
Regional cerebral blood flow in humans at high altitude: gradual ascent and 2 wk at 5,050 m. J Appl Physiol (1985) (2013) 1.01
Synthesis of bovine growth hormone in primates by using a herpesvirus vector. Mol Cell Biol (1985) 1.00
A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis (1997) 1.00
K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res (1997) 0.99
K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett (1997) 0.98
Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Lab Invest (1997) 0.98
[Pharmaco-morbidity linking: a pilot study of its technical possibilities in The Netherlands]. Ned Tijdschr Geneeskd (1990) 0.97
Renal function in summer frogs and winter frogs. J Physiol (1924) 0.97
Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma. Am J Surg Pathol (1996) 0.97
Inhibition of HIV-1 replication using a mutated tRNALys-3 primer. J Biol Chem (1997) 0.95
Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study. J Cancer Res Clin Oncol (2001) 0.95
Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol (1996) 0.94
Measurement of patient compliance. Pharm World Sci (1998) 0.93
A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand (1997) 0.93
Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation (1996) 0.91
Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg (1996) 0.91
HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells. Scand J Immunol (1993) 0.90
Contact site between inner and outer mitochondrial membrane: a dynamic microcompartment for creatine kinase activity. Biochim Biophys Acta (1990) 0.90
Undertreatment of hypertension in a population-based study in The Netherlands. J Hypertens (1998) 0.89
Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma. Lab Invest (2001) 0.88
K-ras-2 and p53 genotyping of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Mod Pathol (1996) 0.87
Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens (1998) 0.87
Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping. Int J Gynecol Pathol (2000) 0.86
Genotypic analysis of pulmonary Langerhans cell histiocytosis. Hum Pathol (2003) 0.85
The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma. Hum Pathol (1996) 0.85
Utilization patterns of non-steroidal anti-inflammatory drugs in an open Dutch population. Pharm Weekbl Sci (1990) 0.85
Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis. Am J Clin Pathol (1996) 0.85
Bispecific antibody-mediated target cell-specific costimulation of resting T cells via CD5 and CD28. Cancer Res (1995) 0.84
Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke (1999) 0.84
Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach. Cancer (1996) 0.83
A genetic analysis of human minor histocompatibility antigens demonstrates Mendelian segregation independent of HLA. Immunogenetics (1993) 0.83
Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells. Transplantation (1990) 0.83
Bridging neurocognitive aging and disease modification: targeting functional mechanisms of memory impairment. Curr Alzheimer Res (2010) 0.83
A rapid method to estimate the incidence rate and prevalence of insulin-dependent diabetes mellitus in children 0-19 years of age. Pharm World Sci (1995) 0.83
Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. J Clin Epidemiol (2000) 0.82
Primary mediastinal and testicular seminomas: a comparison of K-ras-2 gene sequence and p53 immunoperoxidase analysis of 26 cases. Hum Pathol (1996) 0.82
Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production. J Biol Chem (1996) 0.82
Identification of a new lymphocyte subset surface antigen, the expression of which disappears after in vitro and in vivo stimulation. Distribution, biochemistry, and functional studies. Hum Immunol (1986) 0.82
Predictability, controllability, and fear of symptoms of anxiety in epinephrine-induced panic. Biol Psychiatry (1998) 0.82
Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison. Int J Gynecol Pathol (1997) 0.81
Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells. Eur J Immunol (1991) 0.81
Binding of nuclear proteins to HTLV-II cis-acting repressive sequence (CRS) RNA correlates with CRS function. Virology (1994) 0.81
Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study. J Clin Epidemiol (1995) 0.81
Mitochondrial matrix granules: their behavior during changing metabolic situations and their relationship to contact sites between inner and outer mitochondrial membranes. Microsc Res Tech (1994) 0.80
Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. II. Evidence of a possible involvement of proliferative T cells. Transplantation (1990) 0.80
[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more]. Ned Tijdschr Geneeskd (2000) 0.80
Capping of Con A receptors and actin distribution are influenced by disruption of microtubules in Dictyostelium discoideum. Eur J Cell Biol (1990) 0.80
A randomized trial of carboplatin versus iproplatin in untreated advanced ovarian cancer. J Clin Oncol (1991) 0.79
Human keratinocytes activate primed major and minor histocompatibility antigen specific Th cells in vitro. Transpl Immunol (1993) 0.79
Allele specific regulation of cytokine genes: monoallelic expression of the IL-1A gene. Adv Exp Med Biol (2001) 0.79
[Methods to improve patient compliance in the use of antidepressants]. Ned Tijdschr Geneeskd (2002) 0.79
An unexpected finding late after repair of coarctation of the aorta. Neth Heart J (2008) 0.79
Comparative p53 mutational analysis of multiple primary cancers of the upper aerodigestive tract. Surgery (1996) 0.79
K-ras-2 topographic genotyping of pancreatic adenocarcinoma. Arch Surg (1994) 0.79
Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone. Hum Immunol (1995) 0.78
Channelling of controlled release formulation of ketoprofen (Oscorel) in patients with history of gastrointestinal problems. J Epidemiol Community Health (1992) 0.78
Characteristics of current benzodiazepine users as indicators of differences in physical and mental health. Pharm World Sci (2000) 0.78
Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma. Mod Pathol (1999) 0.78
Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands. Pharm World Sci (1993) 0.78
Delayed and persistent suppression of bronchoconstriction by trypsin in the airway lumen. Eur Respir J (2006) 0.77
Escherichia coli cells lacking methylation-blocking factor (leucine-responsive regulatory protein) have precise timing of initiation of DNA replication in the cell cycle. J Bacteriol (1992) 0.77
Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules. Bone Marrow Transplant (1990) 0.77